Women’s health ‘missing out’ because of male-dominated investment

A senior executive in a pharmaceutical company focused on women’s health said the sector is severely undervalued because the investment world is dominated by men. Susanne Fielder, chief commercial officer of Merck spin-off Organon, said that investors often assume that…







